{"id":296480,"date":"2019-10-07T18:00:41","date_gmt":"2019-10-08T01:00:41","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/10\/beijing-gene-complete-b-round\/"},"modified":"2019-10-07T18:59:21","modified_gmt":"2019-10-08T01:59:21","slug":"%e4%b8%ad%e5%9c%8b%e5%90%89%e5%9b%a0%e5%8a%a0%e7%a7%91%e6%8a%80%e5%ae%8c-b-%e8%bc%aa%e8%9e%8d%e8%b3%87","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/10\/%e4%b8%ad%e5%9c%8b%e5%90%89%e5%9b%a0%e5%8a%a0%e7%a7%91%e6%8a%80%e5%ae%8c-b-%e8%bc%aa%e8%9e%8d%e8%b3%87\/","title":{"rendered":"\u4e2d\u570b\u5409\u56e0\u52a0\u79d1\u6280\u5b8c\u6210$2800\u842c\u7684B\u8f2a\u878d\u8cc7"},"content":{"rendered":"<p>\u5317\u4eac\u5409\u56e0\u52a0\u79d1\u6280\u6709\u9650\u516c\u53f8\u5ba3\u4f48\u5b8c\u6210$2800\u842cB\u8f2a\u878d\u8cc7\uff0c\u7531\u57fa\u77f3\u8cc7\u672c\u9818\u6295\uff0c\u4ee5\u63a8\u9032\u5409\u56e0\u52a0\u79d1\u6280\u7684\u816b\u7624\u57fa\u56e0\u6e2c\u8a66\u670d\u52d9\u3002\u5409\u56e0\u52a0\u79d1\u6280\u6b64\u524d\u65bc2016\u5e74\u5b8c\u6210$3000\u842cA\u8f2a\u878d\u8cc7\uff0c\u7531\u4e2d\u570b\u6700\u5927\u7684\u57fa\u56e0\u6e2c\u5e8f\u516c\u53f8\u83ef\u5927\u57fa\u56e0\u9818\u6295\u3002\u83ef\u5927\u57fa\u56e0\u9084\u8207\u677e\u79be\u6295\u8cc7\u3001\u706b\u5c71\u77f3\u8cc7\u672c\u4e00\u8d77\u53c3\u6295B\u8f2a\u878d\u8cc7\u3002\u5409\u56e0\u52a0\u79d1\u6280\u6210\u7acb\u65bc2015\u5e74\u3002\u5409\u56e0\u52a0\u79d1\u6280\u63d0\u4f9b\u6e2c\u8a66\u4ee5\u8a55\u4f30\u500b\u4eba\u7f79\u60a3\u764c\u75c7\u7684\u907a\u50b3\u98a8\u96aa\u4ee5\u53ca\u63d0\u4f9b\u65e9\u671f\u6aa2\u6e2c\u670d\u52d9\u548c\u7cbe\u51c6\u91ab\u5b78\u6307\u5c0e\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aChina Biotoday<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Beijing Gene+ Technology closed a $28 million B round led by Co-Stone to advance its oncology gene testing services. The company&#8217;s $30 million A round, completed in 2016, was led by BGI Group, China&#8217;s largest genetics sequencing company, which also contributed to the B round along with previous investor Green Pine Capital Partners and Volcanics Venture. Founded in 2015 Gene+ offers tests that assess an individual&#8217;s genetic risk for developing cancer as well as early detection services and precision medicine guidance. <\/p>\n","protected":false},"author":9,"featured_media":296474,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563],"class_list":["post-296480","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","sectors-life-science-zh-hant","locations-china-zh-hant","exchange-608"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/296480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=296480"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/296480\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/296474"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=296480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=296480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=296480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}